The next SPAC is here, coming from a pharma e-commerce CEO, as a Florida biotech prices at the low end
The newest healthcare blank-check company has arrived, coming from the CEO of a company that is attempting to shake up the digital pharmaceutical space.
The SPAC known as Aesther Healthcare Acquisition filed for its initial offering late Monday, putting down $100 million as its raise estimate. Led by Suren Ajjarapu, chief executive of online drug marketplace TRxADE Health, the SPAC is targeting pharmaceuticals, medtech and healthcare IT.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.